S'abonner

Patient Reported Outcomes Measurement Information System and Quality of Life in Neurological Disorders Measurement System to Evaluate Quality of Life for Children and Adolescents with Neurofibromatosis Type 1 Associated Plexiform Neurofibroma - 22/02/19

Doi : 10.1016/j.jpeds.2018.10.019 
Jin-Shei Lai, PhD, OTR/L 1, 2, 3, * , Sally E. Jensen, PhD 1, 4, Joel Charrow, MD 2, 5, Robert Listernick, MD 2, 6
1 Department of Medical Social Sciences, Northwestern University Feinberg School of Medicine, Chicago, IL 
2 Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, IL 
3 Division of Hematology, Oncology, Neuro-Oncology & Stem Cell Transplantation, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL 
4 Department of Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL 
5 Division of Genetics, Birth Defects and Metabolism, Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, IL 
6 Division of Academic General, Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, IL 

*Reprint requests: Jin-Shei Lai, PhD, OTR/L, Department of Medical Social Sciences and Pediatrics, Feinberg School of Medicine at Northwestern University, 633 N St Clair, 19th Floor, Chicago, IL 60611.Department of Medical Social Sciences and PediatricsFeinberg School of Medicine at Northwestern University633 N St Clair, 19th FloorChicagoIL60611

Abstract

Objective

To assess the health-related quality of life of children with neurofibromatosis type 1-related plexiform neurofibromas (pNF) using a battery of patient-reported outcome measures selected based on a conceptual framework derived from input by patients, parents, and clinicians regarding the most important pNF symptoms and concerns.

Study design

There were 140 children with pNF ages 8-17 years who completed the Patient-Reported Outcomes Measurement Information System (including domains anxiety, depressive symptom, psychosocial stress experiences, fatigue, pain interference, meaning and purpose, positive affect, peer relationships, physical function-mobility) and Quality of Life in Neurological Disorders measurement system (stigma) via an online platform. T-scores for each measure were compared with US population norms.

Results

Children with pNF reported significantly worse scores than the population norms on 8 of 10 domains. Children with at least 1 family member having a diagnosis of neurofibromatosis type 1 and those having pain reported significantly worse symptoms and functioning on all domains. Boys reported significantly worse pain interference, stigma, meaning and purpose, mobility function, and upper extremity function than girls.

Conclusions

Children with pNF experience significantly worse health-related quality of life on all but 1 domain, highlighting the importance of monitoring children's quality of life over time in clinical research and practice. Future research should evaluate the replicability of these findings and evaluate the validity of the Patient-Reported Outcomes Measurement Information System and Quality of Life in Neurological Disorders measurement system in relation to clinical characteristics among children with pNF.

Le texte complet de cet article est disponible en PDF.

Keywords : quality of Life, patient-reported outcomes, neurofibromatosis type 1, plexiform neurofibrom, pediatric

Abbreviations : CAT, HRQOL, Neuro-QoL, NF1, pNF, PROMIS, QOL


Plan


 This work was supported by an Agreement from the Johns Hopkins University School of Medicine and the Neurofibromatosis Therapeutic Acceleration Program (NTAP). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Johns Hopkins University School of Medicine. The study sponsor provided consultation regarding study design and assistance with recruitment for data collection. The study sponsor was not involved in the analysis/interpretation of data, the writing of the report, or the decision to submit the manuscript for publication. The authors declare no conflicts of interest.


© 2018  Elsevier Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 206

P. 190-196 - mars 2019 Retour au numéro
Article précédent Article précédent
  • Patterns of Pain in Adolescents with Slipped Capital Femoral Epiphysis
  • Mason Uvodich, Richard Schwend, Ognjen Stevanovic, Will Wurster, Julia Leamon, Alec Hermanson
| Article suivant Article suivant
  • Normative Trends in Physically Aggressive Behavior: Age-Aggression Curves from 6 to 24 Months
  • Michael F. Lorber, Tamara Del Vecchio, Amy M.S. Slep, Seth J. Scholer

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.